ABUS Stock Price Prediction

Arbutus Biopharma Corp

Add to Watchlist

Advanced Chart

3.440

+0.030(+0.880%)

Overview
Forecast
Valuation
Earnings

Should I Buy Arbutus Biopharma Corp Stock?

Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. ABUS has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.

ABUS stock price ended at $3.44 on Thursday, after rising 0.88%

The Arbutus Biopharma Corp stock price increased by 0.88% on the last trading day (29 May 2025), rising from 3.42 to 3.44. Throughout the last trading session, the stock experienced a fluctuation of 4.44% , ranging from a day low of $3.38 to a day high of 3.53. The price has declined in 4 of the last 10 days, resulting in a total change of 8.86% during this period. On the last day, trading volume decrease by 153.50K shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 881.38K shares were traded, amounting to approximately 3.05M.

ABUS Technical Signals

ABUS(Arbutus Biopharma Corp Corp) has 4 buy signals and 3 sell signals now. The current trend is downtrend starting from 2025-05-13. The total price change during this trend is +7.84%. Recently, the price has increased significantly with an increase in volume, indicating a strong bullish signal. The average turnover of ABUS over the last 5 trading days is 2.72M. Overall, the technical indicator signals lean more toward a Neutral outlook in the mid-term.

ABUS Moving Average Analysis

Arbutus Biopharma Corp's overall moving average trend leans more bullish as of Friday, May 30, 2025, with 1 negative signals and 3 positive signal. In the mid-term, the SMA_20 being above the SMA_60 signals a strong bullish trend. There will be some resistance from the lines at $3.60771, and $3.835. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $2.8722899999999996, and $2.6449999999999996. A break-down below any of these levels will issue sell signals.

ABUS Short Selling Analysis

The short sale ratio of Arbutus Biopharma Corp(ABUS) as of 27 May 2025 is 20.71%, dropping from last trading day. With decreasing price from 3.22 to 3.45. The short sell activity indicate that short sellers may be experiencing short cover.

Technical Signal

Technical Signals Summary

Neutral

Sell

Buy

Moving Average

Swing

Positive

Stock Price Above SMA_5

Short Term

Positive

SMA_5 Above SMA_20

Mid Term

Positive

SMA_20 Above SMA_60

Long Term

Negative

SMA_60 Below SMA_200

Short Selling

Close Price

Short Sale Ratio

Short Sale Volume

4 Bullish Signals

When Value satisfies Signal, Indicator signals Bullish

Indicators

Signal

Value

Meaning

Awesome Oscillator (5, 34)

AO_5_34 > 0

0.052

Bullish

Momentum (10 days)

MOM_10 > 0

0.28

Bullish

Moving Average Convergence Divergence (12, 26, 9)

MACD_12_26_9 > 0

0.0132

Bullish

Moving Average

5-day SMA crosses above 20-day SMA

Bullish

3 Bearish Signals

When Value satisfies Signal, Indicator signals Bearish

Indicators

Signal

Value

Meaning

Stochastic Oscillator %K (14, 3, 3)

STOCHk_14_3_3 > 80

87.034

Bearish

Stochastic RSI %K (14, 14, 3, 3)

STOCHRSIk_14_14_3_3 > 80

94.379

Bearish

Williams %R (14 days)

WILLR_14 > -20

-15.966

Bearish

ABUS Price Prediction & Forecast by Similar Chart Analysis

Based on historical patterns and backtesting of stocks with similar movements to Arbutus Biopharma Corp(ABUS), our algorithm predicts ABUS's 1-month price at $2.92, with an -5.1%downwardshift. Using a similarity score up to 92.27%and other factors, This forecast updates weekly, adjusting for significant deviations.

Similar Chart

The price prediction chart for Arbutus Biopharma Corp (ABUS.O) stock, as of Sunday, May 18, 2025 , forecasts a -5.1% change over the next month, based on its high correlation with ALEX.N stock patterns. The similarity between their price movements over the analyzed periods is 92.27%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.

ABUS

Future prediction

Up: -5.1%

ALEX

Down: -5.1%Similarity: 92.27%

Name

Similarity

Up/Down

ALEX.N

92.27%

-5.10%

RRR.O

92.21%

-20.99%

FIVE.O

91.85%

-10.02%

GBCI.N

91.65%

-3.06%

UNTY.O

91.57%

+0.84%

BBIO.O

91.23%

-1.39%

MTLS.O

91.11%

+14.67%

TPST.O

91.01%

+8.33%

PBI.N

90.99%

+33.55%

GIGM.O

90.99%

+0.71%

ABUS Seasonality Analysis

Based on ABUS's historical stock price data across all years, the probability of a positive return in May is36.36%, suggesting it maynotbe an ideal month to invest in ABUS. In contrast,Februaryoffers the highest probability of positive returns at72.73%, making it a potentially strong month for investment.

However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.

Monthly Seasonality

The radar chart shows that buying Arbutus Biopharma Corp (ABUS.O) stock in February has the highest probability of a positive return (72.73%), while October has the lowest probability (10.00%).

Performance Seasonality

The chart shows Arbutus Biopharma Corp. (ABUS)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.